arrow
J

John P. Overington

xyme ai ltd
H指数:54
被引数:3.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma

万德他尼联合依维莫司治疗ACVR1-Mutant弥漫性内在性脑桥胶质瘤

2021-09-2229
OAAI
Setting Our Sights on Infectious Diseases

将目光投向传染病

2019-12-0618
OAAI
Unexplored therapeutic opportunities in the human genome (vol 17, pg 317, 2018)

人类基因组中未开发的治疗机会 (第17卷,317页,2018页)

2018-03-2323
OAAI
Unexplored therapeutic opportunities in the human genome

人类基因组中未开发的治疗机会

2018-03-23278
OAAI
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions

药物目标共享: 为药物-目标相互作用建立共识知识库的社区努力

2018-02-01102
OAAI
Pharos: Collating protein information to shed light on the druggable genome

Pharos: 整理蛋白质信息以阐明可药用基因组

2016-11-29189
OAAI
The ChEMBL database in 2017

ChEMBL数据库2017年

2016-11-281.6K
OAAI
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles

开源药物发现: 源自Tres Cantos芳基吡咯的高效抗疟化合物

2016-09-1454
OAAI